DE60121027D1 - Lösung zur evaluierung und konservierung - Google Patents

Lösung zur evaluierung und konservierung

Info

Publication number
DE60121027D1
DE60121027D1 DE60121027T DE60121027T DE60121027D1 DE 60121027 D1 DE60121027 D1 DE 60121027D1 DE 60121027 T DE60121027 T DE 60121027T DE 60121027 T DE60121027 T DE 60121027T DE 60121027 D1 DE60121027 D1 DE 60121027D1
Authority
DE
Germany
Prior art keywords
concentration
evaluation
preservation
solution
scavenger
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121027T
Other languages
English (en)
Other versions
DE60121027T3 (de
DE60121027T2 (de
Inventor
Stig Steen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xvivo Perfusion Goeteborg Se AB
Original Assignee
Vitrolife AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26655291&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60121027(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0004032A external-priority patent/SE0004032D0/xx
Application filed by Vitrolife AB filed Critical Vitrolife AB
Publication of DE60121027D1 publication Critical patent/DE60121027D1/de
Application granted granted Critical
Publication of DE60121027T2 publication Critical patent/DE60121027T2/de
Publication of DE60121027T3 publication Critical patent/DE60121027T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
DE60121027T 2000-11-03 2001-11-05 Lösung zur evaluierung und konservierung Expired - Lifetime DE60121027T3 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0004032 2000-11-03
SE0004032A SE0004032D0 (sv) 2000-11-03 2000-11-03 Evaluerings- och preservationslösning
US27972501P 2001-03-30 2001-03-30
US279725P 2001-03-30
PCT/SE2001/002419 WO2002035929A1 (en) 2000-11-03 2001-11-05 Evaluation and preservation solution

Publications (3)

Publication Number Publication Date
DE60121027D1 true DE60121027D1 (de) 2006-08-03
DE60121027T2 DE60121027T2 (de) 2007-01-04
DE60121027T3 DE60121027T3 (de) 2011-06-09

Family

ID=26655291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121027T Expired - Lifetime DE60121027T3 (de) 2000-11-03 2001-11-05 Lösung zur evaluierung und konservierung

Country Status (10)

Country Link
US (4) US7255983B2 (de)
EP (1) EP1339279B2 (de)
CN (1) CN100381048C (de)
AT (1) ATE330468T1 (de)
AU (2) AU2002214443B2 (de)
CA (1) CA2427765C (de)
DE (1) DE60121027T3 (de)
ES (1) ES2263674T5 (de)
HK (1) HK1058610A1 (de)
WO (1) WO2002035929A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8409846B2 (en) 1997-09-23 2013-04-02 The United States Of America As Represented By The Department Of Veteran Affairs Compositions, methods and devices for maintaining an organ
CA2427765C (en) * 2000-11-03 2012-01-24 Vitrolife Ab Evaluation and preservation solution
DE10326764A1 (de) * 2003-06-13 2004-12-30 Biotest Ag Endothel-protektive Perfusionslösung, eine Apparatur und Verfahren zur Konservierung des Endothels in isolierten Hohlorganen und biologischen Gefäßen
US9055740B2 (en) 2004-10-07 2015-06-16 Transmedics, Inc. Systems and methods for ex-vivo organ care
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US9301519B2 (en) * 2004-10-07 2016-04-05 Transmedics, Inc. Systems and methods for ex-vivo organ care
WO2006052133A2 (en) * 2004-11-12 2006-05-18 Doorzand Airdrive B.V. Composition for cold preservation and perfusion of organs
US9078428B2 (en) 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
WO2007009981A1 (en) * 2005-07-15 2007-01-25 Medizinische Hochschule Hannover Medium and process for tissue cultivation
CA2881613C (en) * 2006-04-19 2017-11-14 Stanley Kyi Systems and methods for ex vivo organ care
US9457179B2 (en) 2007-03-20 2016-10-04 Transmedics, Inc. Systems for monitoring and applying electrical currents in an organ perfusion system
SE531453C2 (sv) * 2007-07-06 2009-04-07 Xenodevice Ab System för organevaluering och -preservation
US8835104B2 (en) * 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
US10750738B2 (en) * 2008-01-31 2020-08-25 Transmedics, Inc. Systems and methods for ex vivo lung care
US8871434B2 (en) * 2008-03-21 2014-10-28 Fenwal, Inc. Red blood cell storage medium for extended storage
US8968992B2 (en) * 2008-03-21 2015-03-03 Fenwal, Inc. Red blood cell storage medium for extended storage
US20110065169A1 (en) * 2008-05-06 2011-03-17 Vivoline Medical Ab Apparatus for housing an organ during evaluation and preservation
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
US9084416B2 (en) 2009-09-25 2015-07-21 Vivoline Medical Ab Container and supporting structure for housing an organ
WO2011049709A1 (en) 2009-10-23 2011-04-28 Fenwal, Inc. Methods and systems for providing red blood cell products with reduced plasma
SE534862C2 (sv) * 2010-05-14 2012-01-24 Vivoline Medical Ab Användning av en medicinsk vätska för behandling av ett uttaget organ
JP2014518547A (ja) 2011-04-07 2014-07-31 フェンウォール、インコーポレイテッド 削減された残存血漿容積を有する血小板濃縮物を提供するための自動化方法とシステムおよびそのような血小板濃縮物のための貯蔵媒体
CN114375945A (zh) * 2011-04-14 2022-04-22 特兰斯迈迪茨公司 用于供体肺的离体机器灌注的器官护理溶液
CA2774383A1 (en) 2011-06-22 2012-12-22 Shaf Keshavjee Repaired organ and method for making the same
EP2763526A4 (de) * 2011-10-03 2015-06-03 Vivoline Medical Ab Medizinische flüssigkeit mit globulin und ihre verwendung zur konservierung von entnommenen organen
US10433538B2 (en) * 2012-10-12 2019-10-08 University of Pittsburgh—of the Commonwealth System of Higher Education Compositions and methods for organ preservation
US9888680B2 (en) * 2013-04-04 2018-02-13 The Trustees Of Columbia University In The City Of New York Functional recovery of human lungs for transplantation
EP2821081A1 (de) 2013-07-05 2015-01-07 ResuSciTec GmbH Schützende Lösung zum Verhindern oder Verringern von Reperfusionsschäden des Gehirns und des ganzen Körpers
WO2015168540A1 (en) * 2014-05-01 2015-11-05 Berry Catherine E A modified single dose, microplegic approach to cardioplegia for the adult heart
CN113287600B (zh) 2014-06-02 2022-08-19 特兰斯迈迪茨公司 对离体肝脏灌注的灌注回路和系统以及对其保存的系统
CN104542578B (zh) * 2015-02-05 2017-01-18 广州赛莱拉干细胞科技股份有限公司 一种细胞保存液及其制备方法、应用
CA2981588A1 (en) 2015-04-03 2016-10-06 Tx Innovations B.V. Organ preservation composition
GB201505987D0 (en) * 2015-04-08 2015-05-20 Univ Dublin A lung perfusion solution and use thereof for the ex-vivo preservation of a mammalian lung
FR3035407B1 (fr) 2015-04-23 2022-06-17 Francais Du Sang Ets Procede de conservation de cellules, tissus ou organes en hypothermie
CN104804556A (zh) * 2015-04-28 2015-07-29 北京建筑大学 一种用于金属表面的新型绿色防腐涂料及其用途
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
US10194655B2 (en) 2015-09-09 2019-02-05 Transmedics, Inc. Aortic cannula for ex vivo organ care system
FR3040860B1 (fr) * 2015-09-10 2020-05-15 Universite de Bordeaux Milieu de conservation injectable pour la conservation de cellules du sang placentaire, de la moelle osseuse et du sang peripherique
US20200349863A1 (en) 2016-02-04 2020-11-05 Xvivo Perfusion Ab Ex vivo lung simulator
CN105954526B (zh) * 2016-04-26 2017-10-10 南华大学 一种胰岛素的酶免疫测定方法
US10091986B2 (en) 2016-05-09 2018-10-09 Xor-Labs Toronto Inc. Organ perfusion device and method
RU2737147C1 (ru) * 2017-01-17 2020-11-25 Эксвиво Перфьюжн Аб Растворы для консервации и/или перфузии органов
CN107980767B (zh) * 2018-01-10 2018-10-30 暨赛再生医学科技有限公司 一种长期保存过表达ang-1的epc的保存液
WO2020026212A2 (en) 2018-08-03 2020-02-06 VeriGraft AB Methods of preparing personalized blood vessels
CN113677200B (zh) * 2019-04-12 2023-09-26 乌格勒希研究有限公司 用于修复器官的方法和装置
KR20210151202A (ko) * 2019-04-12 2021-12-13 유지엘케이 사이언스 에이비 신장 이식을 위한 방법 및 장치
CN111700063B (zh) * 2020-06-29 2021-03-30 广州瑞铂茵健康科技有限公司 一种脐带标本的保存方法
GB202011427D0 (en) 2020-07-23 2020-09-09 Xvivo Perfusion Ab Organ preservation and/or perfusion solution
US20240049700A1 (en) * 2021-01-04 2024-02-15 Biosip Ab Lipid layer preservation
WO2022233642A1 (en) 2021-05-06 2022-11-10 Xvivo Perfusion Ab Methods for removing leucocytes from isolated organs
WO2024018452A1 (en) 2022-07-18 2024-01-25 Yeda Research And Development Co. Ltd. Albumin protein variants, production thereof and uses of same
WO2024018051A1 (en) 2022-07-22 2024-01-25 Grifols Worldwide Operations Limited Stable plasmin compositions for organ preservation and reconditioning

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE940059C (de) * 1953-03-12 1956-03-08 Behringwerke Ag Verfahren zur Herstellung von Infusionspraeparaten zur Kreislaufauffuellung
SU1109110A1 (ru) 1981-06-30 1984-08-23 Институт Физиологии Им.А.И.Караева Состав дл консервировани печени
NO166836C (no) 1985-03-14 1991-09-11 Univ California Fremgangsmaate for behandling av et organtransplantat.
JPS62151155A (ja) 1985-09-17 1987-07-06 Ajinomoto Co Inc チ−ズホエ−を原料とする調味料の製造方法
US4798824A (en) 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US4898824A (en) * 1986-12-09 1990-02-06 Miles Inc. Crosslinked polyacrylamide-sulfhydryl polymer for immobilization of biologically active substances
US5051352A (en) 1987-10-07 1991-09-24 The Regents Of The University Of California Apparatus and method of preserving the viability of animal organs
US4920044A (en) 1988-11-08 1990-04-24 The Cleveland Clinic Foundation Intracellular flush solution for preserving organs
GB9024223D0 (en) 1990-11-07 1990-12-19 Fermentech Ltd Production of hyaluronic acid
US5217860A (en) 1991-07-08 1993-06-08 The American National Red Cross Method for preserving organs for transplantation by vitrification
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
AU6409594A (en) † 1993-03-16 1994-10-11 Alliance Pharmaceutical Corporation Preservation solution and method for warm organ preservation
US5360389A (en) 1993-05-25 1994-11-01 Chenette Philip E Methods for endometrial implantation of embryos
ATE199626T1 (de) * 1993-06-04 2001-03-15 Biotime Inc Plasma-artige lösung
US6375613B1 (en) 1994-05-20 2002-04-23 Breonics, Inc. Prognostic testing of organs intended for transplantation
WO1995031897A1 (en) 1994-05-20 1995-11-30 Vec Tec, Inc. Method and apparatus monitoring viability of transplantable organs
US5643712A (en) 1994-05-20 1997-07-01 Brasile; Lauren Method for treating and rendering grafts nonthrombogenic and substantially nonimmunogenic using an extracellular matrix coating
US5580714A (en) 1995-03-08 1996-12-03 Celox Laboratories, Inc. Cryopreservation solution
SE505499C2 (sv) * 1995-12-15 1997-09-08 Stiftelsen Facthor Förvaringslösning för organ och vävnad eller delar därav från människor och djur innehållande kalcium och nitroglycerin, användning därav samt förfarande för förvaring därmed
IT1287227B1 (it) 1996-04-04 1998-08-04 Fidia Spa In Amministrazione S Acido ialuronico quale componente del liquido di conservazione della cornea
US5843024A (en) 1996-05-17 1998-12-01 Breonics, Inc. Solution and process for resuscitation and preparation of ischemically damaged tissue
DE19652922C2 (de) 1996-12-19 1999-07-29 O & K Mining Gmbh Hydraulikschaltung für einen Hydraulikbagger
US5948609A (en) 1997-12-03 1999-09-07 Carter; Daniel C. Oxygen-transporting albumin-based blood replacement composition and blood volume expander
JPH11246301A (ja) * 1998-02-27 1999-09-14 Denki Kagaku Kogyo Kk 臓器保存溶液
GB9902412D0 (en) 1999-02-03 1999-03-24 Fermentech Med Ltd Process
GB9902652D0 (en) 1999-02-05 1999-03-31 Fermentech Med Ltd Process
CA2427765C (en) * 2000-11-03 2012-01-24 Vitrolife Ab Evaluation and preservation solution

Also Published As

Publication number Publication date
AU1444302A (en) 2002-05-15
ES2263674T5 (es) 2011-04-01
CN1477926A (zh) 2004-02-25
ES2263674T3 (es) 2006-12-16
US20110269112A1 (en) 2011-11-03
CA2427765C (en) 2012-01-24
ATE330468T1 (de) 2006-07-15
EP1339279A1 (de) 2003-09-03
AU2002214443B2 (en) 2005-12-15
WO2002035929A1 (en) 2002-05-10
DE60121027T3 (de) 2011-06-09
EP1339279B1 (de) 2006-06-21
US7255983B2 (en) 2007-08-14
US20150150240A1 (en) 2015-06-04
US20080057488A1 (en) 2008-03-06
US8980541B2 (en) 2015-03-17
US20040029096A1 (en) 2004-02-12
EP1339279B2 (de) 2010-11-17
DE60121027T2 (de) 2007-01-04
US8012677B2 (en) 2011-09-06
CA2427765A1 (en) 2002-05-10
CN100381048C (zh) 2008-04-16
HK1058610A1 (en) 2004-05-28

Similar Documents

Publication Publication Date Title
ATE330468T1 (de) Lösung zur evaluierung und konservierung
ATE497385T1 (de) Neue phenylalanin-derivate
ATE442851T1 (de) 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a
ATE355269T1 (de) Phenylalaninderivate
EP1050297A3 (de) Eine Lotion enthaltende Gewebe enthaltend eine pH-Buffer Verbindung für die Haut
FR2785501B1 (fr) Solution de perfusion et/ou de conservation et/ou de reperfusion lors de la transplantation d'organes
CY1107496T1 (el) Ρυθμισμενες συνθεσεις για διαλυση
EA200100300A1 (ru) Сухой порошок, содержащий действующее вещество, и способ доставки в легкие пациента действующего вещества
JP2005516024A5 (de)
DE50211566D1 (de) Kombination ausgewählter opioide mit muscarin-antagonisten zur therapie der harninkontinenz
BR0010314A (pt) Solução aquosa de conservação de tecidos e órgãos
ES2160649T3 (es) Nuevos compuestos lactamicos y procedimientos para su preparacion.
SE0102147D0 (sv) New methods
SE9504505D0 (sv) Förvaringslösning
DE69218816T2 (de) N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
DK0918469T3 (da) Fremgangsmåder og præparater til at øge den vævsanaerobe arbejdskapacitet
DE60123528D1 (de) Verwendung eines Mittels zur Verbesserung der Astrozytenfunktion zur Behandlung von Parkinsons Krankheit
DE60007548D1 (de) Omega kettenmodifizierte hydroxyeicosatetraensäure derivate verwendbar in der behandlung der "trockenes auge" krankheit
DE69904658T2 (de) Gegen Ralstonia Solanacearum aktive bakterizide Zusammensetzungen
RU97111095A (ru) Препарат для профилактики и лечения гельминтозов животных "альбамелин"
FR2832157B1 (fr) Procede de preparation d'un principe actif a base de proteines polymerisees,principe actif et composition a effet lissant, anti-rides et tenseur immediat de la peau
RU96110047A (ru) Способ профилактики эндометрита после кесарева сечения
IT1244615B (it) Composizione sterilizzante
FI961029A0 (fi) Menetelmä maksasairauden ja vastaavien indikaatioiden hoitamiseksi vasodilatoivilla aineilla
ATE329613T1 (de) Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: XVIVO PERFUSION AB, GOETEBORG, SE